K945195

Substantially Equivalent

ABUSCREEN ONLINE PROPOXPHENE

Applicant: Roche Diagnostic Systems, Inc.
Product code: JXN
Advisory panel: Clinical Toxicology
Date received: 1994-10-24
Decision date: 1994-12-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Branchburg, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.